aim market - grant thornton australia · meditech china healthcare 107 1,542 abcam uk healthcare...

12
MARCH 2016 AIM Market Growth funding opportunities for Australian companies

Upload: others

Post on 07-Oct-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

MARCH 2016

AIM MarketGrowth funding opportunities for Australian companies

Page 2: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

2 AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016

03 Executive summary

04 Why consider an AIM admission?

05 AIM companies

06 Key sectors

07 New admissions to AIM in 2015

08 International companies on AIM

09 Australian companies on AIM

10 Case study – Tlou Energy

11 Could an AIM admission be right for you?

12 Contact Grant Thornton

Contents

Page 3: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016 3

Executive summary

During 2015, new admissions to AIM raised £1.2 billion (over A$2.4 billion)and there was an increased trend across the market towards a reduced number of high quality investments in larger companies. The average market capitalisation of AIM companies increased from £64.7 million (A$131.6 million) at 31 December 2014 to £70.0 million (A$142.4 million) at 31 December 2015. In addition, further fundraisings by existing AIM companies increased 32% to £4.3 billion (A$8.7 billion) compared with £3.2 billion (A$6.5 billion) in 2014. The sectors with the highest fundraising activity levels were Health Care, Financials and Consumer Services.

There were four Australian companies admitted to AIM during 2015, all of which were in the resources sector. Of these, the largest fundraising was by IronRidge Resources Limited, which raised £9.7 million (A$19.7 million) on admission to AIM in February 2015 and at admission had a market capitalisation of £25.4 million (A$51.6 million).

An AIM admission appeals to companies in growth sectors that are looking to attract sophisticated investors with longer term investment horizons. Currently there is strong institutional investor interest in companies in sectors such as Technology, Health Care, Financial Services, Biotechnology and Online Retail.

Comparative AIM and ASX returns: January 2013 to December 2015:AIM performed well above the Small Ordinaries Index of the Australian Securities Exchange (ASX) over the 3 years to 31 December 2015. The chart below shows the comparative returns, over the period January 2013 to December 2015, of the FTSE AIM All Share index, the S&P/ASX All Ordinaries and the S&P/ASX Small Ordinaries indices.

The AIM market was launched in June 1995 by the London Stock Exchange and is now the most successful growth market in the world. AIM provides growth companies with access to an international pool of investor capital.

Key attributes of Australian businesses that are likely to be attractive to AIM investors include:

1 Strong management teams with good track records

2 Good growth prospects

3 A proven business model, with businesses ideally having reached profitability

4An international flavour to the business, particularly businesses that have strong growth opportunities in the UK and Europe

Australian companies with international businesses that would benefit from the increased exposure of an international listing should consider accessing the growth funding opportunities presented by an AIM IPO or dual listing.

Source: S&P Capital IQ

30.00%

25.00%

20.00%

15.00%

10.00%

0.05%

0.00%

-0.05%

-10.00%

-15.00%

-20.00%

-30.00%

Jan-20

13

Oct-20

13

May-20

13

Mar-20

14

Sep-2

014

Apr-2

015

Aug-2

015

Feb-2

013

Dec-20

13

Jul-20

13

May-20

14

Nov-20

14

May-20

15

Oct-20

15

Apr-2

013

Jan-20

14

Aug-2

014

Feb-2

015

Sep-2

013

Jun-20

14

Dec-20

14

Jul-20

15

Dec-20

15

—— FTSE AIM All-Share (^AXX) – Index Value —— S&P/ASX All Ordinaries Index (^XA0) – Index value —— S&P/ASX Small Ordinaries Index (^XS0) – Index value

Page 4: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

4 AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016

Why consider an AIM admission?

Key attractions of AIMFor internationally focused Australian companies, the key attractions of the AIM market include:

1 Access to the UK capital market, one of the deepest pools of capital in the world

2 Access to international institutional investors

3 Higher valuations may be achieved by some businesses due to the focus on growth companies

4 Potential to raise the international profile of the business, to assist in expanding into new markets

5 Simplified regulatory environment, specifically designed for the needs of growing companies

6 No minimum entry criteria in relation to company size, track record, number of shares in public hands etc.

The AIM market provides mid-sized growing companies with the opportunity to raise capital and a liquid marketplace to trade shares.

AIM is the world’s leading growth market and benefits from being an integral part of the London Stock Exchange, one of the world’s leading securities exchanges and a hub for global capital.

Admission criteriaThe AIM Rules have been designed for smaller; growing companies hence, the admission criteria are more flexible than many other markets, these include:

• No minimum market capitalisation• No minimum trading history• No requirement for shareholder spread• No minimum share price• Shares must be freely transferable and electronically tradeable• Companies must have 12 months working capital at admission

to AIM• Companies must appoint a Nominated Advisor (“Nomad”) to

determine suitability for admission to AIM and give guidance on the AIM Rules

AIM companies must appoint and retain a Nomad, who is responsible for ensuring that the company is suitable for admission. As part of this role, the Nomad will project manage the admission process, advise and guide on the AIM rules, coordinate the advisers in the due diligence process, assist with broker selection and help prepare the Admission Document.

Dual listingsASX listed companies may be eligible to be admitted under the Designated Market or “fast-track” rules, which remove the need for a full Admission Document (the equivalent to an ASX prospectus).

Page 5: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016 5

AIM companies

There were 1,044 companies listed on AIM as at 31 December 2015, with a combined market capitalisation of £73.1 billion (A$148.7 billion).

This compares to 2,108 companies listed on the ASX at 31 December 2015, which had a combined market capitalisation of A$1.6 trillion. In the UK, the largest companies including banks and other financial institutions are listed on the Main Market of the London Stock Exchange, which had 919 listed companies as at 31 December 2015, with a combined market capitalisation of £2.2 trillion (A$4.5 trillion). In Australia the Australian Securities Exchange includes companies of all sizes on the one market and the ASX 200 accounted for a combined market capitalisation of A$1.2 trillion at 31 December 2015. For a more realistic comparison of the AIM and ASX markets, if we exclude the ASX 200, the average market capitalisation of an ASX-listed company is A$18.5 million which is significantly lower than the average market capitalisation of an AIM company of A$130.1 million as at 31 December 2015.

ASOS PLC was the largest company on AIM as at 31 December 2015, with a market capitalisation of £2.8 billion (A$5.7 billion). ASOS is the UK’s largest online-only fashion store which markets fast fashion to consumers aged 16 to 34 years old. ASOS has been growing strongly on the back of its organic growth strategies as well as strategic investments in its technology, warehousing and distribution systems. During 2015, ASOS reported revenues of £1.1 billion (A$2.2 billion) and the company’s shares were the most actively traded security on the AIM Market during the year.

Distribution of companies on AIM by market capitalisation at 31 December 2015

Top 10 AIM companies by market capitalisation at 31 December 2015

Company Country of operation Sector Revenue*

(£m)

Market capitalisation

(£m)

ASOS UK Consumer Services 1,151 2,879

NEW EUROPE PROPERTY INVESTMENTS PLC

Central & Eastern Europe Financials 102 2,425

HUTCHISON CHINA MEDITECH China Healthcare 107 1,542

ABCAM UK Healthcare 144 1,324

MARKET TECH HLDG LTD UK Financials 83 991

GW PHARMACEUTICALS USA Healthcare 29 990

JAMES HALSTEAD UK Industrials 227 987

DART GROUP PLC UK Consumer Services 1,375 844

CLINIGEN GROUP PLC UK Healthcare 184 802

ORIGIN ENTERPRISES PLC UK Consumer Goods 1,105 757

Total 13,541

* Revenue is based on the latest financial report available

Source: AIM December 2015 factsheet and latest financial reports

Source: AIM December 2015 factsheet

0

50

99

0 - 2 2 - 5 5 - 10 10 - 25 25 - 50 50 - 100 100 - 250

250 - 500

500 - 1000

Over 1000

144

122

197

151

123107

51

184

100

150

200

250

Market capitalisation range £m

No. o

f com

pani

es

Page 6: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

6 AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016

Key sectors

The AIM market is comprised of a diverse range of companies across many sectors. Key market sectors include resources (oil & gas and basic materials), financials (including real estate, equity investment instruments and general financial services), industrials (including construction & materials, electronics & electrical equipment and support services), consumer services (including media and travel & leisure) and information technology (IT).The key sectors by market capitalisation are financials and consumer services which accounted for 22% and 17% of the market respectively as at 31 December 2015.

Fundraisings by existing AIM companies during 2015 were dominated by the Health Care and Financials sectors which accounted for 37% and 21% of total raisings, respectively. Specifically within the Health Care sector, there were 206 secondary placings which raised £2.0 billion (A$4.1 billion) during 2015. Within the Financials sector, there were 227 secondary placings which collectively raised £1.1 billion (A$2.2 billion).

Basic Materials - 8%Consumer Goods - 2%Consumer Services - 6%Financials - 21%Health Care - 37%Industrial - 14%IT - 4%Oil & Gas - 6%Telecommunications - 1%Utilities - 1%

Distribution of secondary funds raised by AIM in 2015 by sectorSource: AIM December 2015 factsheet

Basic Materials - 5%Consumer Goods - 8%Consumer Services - 17%Financials - 22%Health Care - 15%Industrials - 15%IT - 10%Oil & Gas - 5%Telecommunications - 2%Utilities - 1%

Distribution of market capitalisation of companies on AIM by sector at 31 December 2015Source: AIM December 2015 factsheet

Number of companies on AIM by sector at 31 December 2015Source: AIM December 2015 factsheet

Basic Materials - 15%Consumer Goods - 6%Consumer Services - 11%Financials - 19%Health Care - 8%Industrials - 17%IT - 11%Oil & Gas - 11%Telecommunications - 1%Utilities - 1%

15%

11%

19%8%

17%

11%

11%

1% 1%

6%

5%8%

8% 2%

6%

21%

37%

14%

4%6%

1%

17%

22%15%

15%

10%

5%

2% 1% 1%

Page 7: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016 7

Fund raisings on new Admissions to AIM

Source: AIM December 2015 factsheet

New admissions to AIM in 2015

In aggregate £1.2 billion (over A$2.4 billion) was raised through new admissions during 2015, with an average raising on admission to AIM of £19.0 million (A$38.6 million). The number of new admissions to AIM in 2015 decreased significantly from 2014, when there were 118 new admission raising a total of £2.6 billion (A$5.2 billion). However, this appears to be in part, a structural shift across the AIM market towards investors favouring higher quality assets of larger companies. This is evidenced by the number of AIM listed companies decreasing by 60 over the course of 2015 and the average market capitalisation of AIM companies increasing from £64.7 million (A$131.6 million) as at 31 December 2014 to £70.0 million (A$142.4 million) as at 31 December 2015.

Top 10 new admissions to AIM in 2015Company Sector Funds raised (£m)

ZEGONA COMMUNICATIONS PLC Financials 251

BENCHMARK HLDGS PLC Health care 186

CONVIVIALITY PLC Consumer services 130

ALLIANCE PHARMA Health care 79

APPLEGREEN PLC Consumer Goods 51

MARSHALL MOTOR HLDGS PLC Consumer Goods 40

DALATA HOTEL GROUP PLC Consumer services 38

ELEGANT HOTELS GROUP PLC Consumer services 32

GLOO NETWORKS PLC Financials 30

ZEGONA COMMUNICATIONS PLC Financials 30

Total 867

Source: AIM December 2015 factsheets

New admissions to AIM in 2015 were dominated by companies in the Health Care, Financials and Consumer Services sectors, which accounted for 31%, 31% and 27%, respectively, of all fund raisings by new AIM companies.

The largest admission during 2015 was that of Zegona Communications PLC. Zegona was established by former Virgin Media executives to acquire and operate businesses in the Telecommunications, Media and Technology sector with a “Buy-Fix-Sell” strategy and was originally admitted to AIM

in March 2015 raising £30.0 million (A$61.0 million). Zegona then acquired Telecable in August 2015 and was readmitted to AIM raising a further £251.0 million (A$510.6 million) to fund the cash consideration of the acquisition. Shortly after, Zegona announced its intention to list on the Main Market of the London Stock Exchange to continue its acquisition strategy, the company was listed on the Main Market on 29 September 2015. This is a good example of a company that has used the AIM market to successfully raise significant growth funding in a short timeframe.

The second largest admission to AIM in 2015 was the re-admission of Benchmark Holdings. Benchmark Holdings is an innovation company, operating and consolidating businesses in the global food production sector. Benchmark acquired Inve Aquaculture a specialist manufacturer of aquaculture and nutrition health products. The size of the transaction constituted a reverse takeover under the AIM rules and Benchmark Holdings was re-admitted to AIM on 30 December 2015 raising £185.7 million (A$377.7 million) to fund the cash consideration of the acquisition.

3,000

2,500

2,000

1,500

1,000

500

0

1,108

2008 2009 2010 2011 2012 2013 2014 2015

740

1,219

609520

1,187

2,599

1,158

Tota

l Fun

drai

sing

£m

Page 8: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

8 AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016

International companies on AIM

International AIM companies December 2015

Country of operation

No. of companies

Total market capitalisation (£m)

Average market capitalisation (£m)

Western Europe 63 6,306 100

Africa 61 1,750 29

USA 46 1,751 38

Australia 42 611 15

China 33 2,393 73

Asia Pacific 33 1,603 49

Russia & CIS 32 1,016 32

Latin America 21 641 31

India & Bangladesh 21 1,334 64

Central & Eastern Europe 14 2,775 198

Israel 14 787 56

Canada 13 324 25

Middle East 7 122 17

Other Offshore 4 189 47

Isle of Man 3 44 15

Channel Islands 1 13 13

Total 408 21,659 53

International companies listed on AIM as at 31 December 2015 by countrySource: AIM December 2015 Country of Operation and Incorporation Report and Grant Thornton analysis

Africa - 15%

Asia Pacific - 8%

Australia - 11%

Canada - 3%

Central & Eastern Europe - 3%

Channel Islands - 1%

China - 8%

India & Bangladesh - 5%

Isle Of Man - 1%

Israel - 3%

Latin America - 5%

Middle East - 2%

Other Offshore - 1%

Russia & CIS - 8%

USA - 11%

Western Europe - 15%

Internationally incorporated companies represented 32% of the companies admitted on AIM as at 31 December 2015. However, the actual proportion of international businesses is significantly higher as many companies incorporate a UK holding company for the purpose of their AIM admission.

Unsurprisingly, the largest companies on AIM are domestic UK companies whose average market capitalisation was £81.0 million (A$164.7 million) as at 31 December 2015, compared with £51.0 million (A$103.7 million) for international companies. Western Europe and Africa are the next largest regions by currently admitted companies. African companies are mostly resource extraction companies with operations throughout continental Africa. The regions with the highest average market capitalisation as at 31 December 2015 were Western Europe and Central & Eastern Europe.

15%

8%

11%

11%

15%

3%3%

8%

8%

5%5%2%

3%

1%1%

1%

Currently there is strong investor interest for businesses operating in the technology, financial services, online retail and health care sectors. This provides opportunities for established Australian businesses with an international market for their products or services to raise capital and increase their global profile.

Source: AIM December 2015 Country of Operation and Incorporation Report and Grant Thornton analysis

Page 9: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016 9

Australian companies on AIM

Top 10 Australian AIM listed companies by market capitalisation as at 31 December 2015

Company SectorMarket

capitalisation (£m)

Mysale Group Plc Consumer services 68

Wolf Minerals Ltd Basic Materials 65

Seeing Machines IT 47

Berkeley Energia Ltd Basic Materials 47

Coal Of Africa Ltd Basic Materials 47

Churchill Mining Plc Basic Materials 29

Jubilee Platinum Basic Materials 29

Hydrodec Group Oil & gas 25

Range Resources Oil & gas 23

Solgold Plc Basic Materials 17

Total 397

Source: AIM December 2015 factsheet and Country of Operation and Incorporation Report LSE Website, S&P Capital IQ.

The largest Australian AIM listed company by market capitalisation as at 31 December 2015 was discount ‘flash sales’ retailer Mysale Group, which was admitted to AIM in June 2014. In 2015 other key performing Australian AIM companies included;

• Wolf Minerals – The second largest Australian AIM listed company by market capitalisation as at 31 December 2015. Wolf Minerals is a specialty metals and global tungsten producer operating out of Devon UK. Wolf Minerals was admitted to AIM in November 2011. The company completed the commissioning of its processing plant at Drakelands Mine (Devon) in September 2015 and its first shipment of concentrate represents the company’s maiden revenue. This was a significant achievement given global market conditions in the resources and commodities sectors during 2015.

• Ironridge Resources Limited – Ironridge Resources is a company focussed on the discovery and development of world-class and globally-demanded commodities. Ironridge Resources IPO raised £9.7 million (A$19.7 million) and on admission to AIM, the company had a market capitalisation of £25.4 million (A$51.7 million).

New Australian admissions to AIM during 2015 were dominated by the basic materials (60%) and Industrials (28%) sectors.

The vast majority of other Australian AIM admitted companies are in the resources sector (basic materials or oil & gas). Many of the larger Australian AIM companies are dual-listed on the ASX, for example, Wolf Minerals, Base Resources, Eservglobal, Range Resources and Oilex.

A fast-track admission route (also known as the AIM designated market route) may be available for ASX-listed issuers that have been listed for at least 18 months. The key benefit of a fast-track process is the removal of the requirement to produce a full Admission Document (the equivalent of a prospectus).

Australian AIM admitted companies by sector as at 31 December 2015Source: AIM December 2015 Country of Operation and Incorporation Report and Grant Thornton analysis

Basic Materials - 60%

Industrial - 28%

IT - 2%

Oil & Gas - 5%

Consumer Goods - 5%

60%

28%

2%5%

5%

An AIM admission can be an effective mechanism for Australian companies with global assets or business operations to access funding from institutional investors and to raise their profile internationally.

Page 10: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

10 AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016

Background to dealTlou Energy Limited (“Tlou” or the “Company”) is a Coalbed Methane (CBM) natural gas explorer and pilot producer with interests in southern Africa. Its principal assets are based in Botswana, where it has one of the most advanced CBM projects in the country.

Botswana is one of Africa’s most stable countries and its recent economic growth has been high by African standards. It is the world’s largest exporter of diamonds but has recently been seeking to reduce its economic dependence on diamonds, moving to boost local business and employment in other sectors.

Tlou was set up to supplement the energy needs of the rapidly growing southern African region through supplying natural CBM gas to generate new electrical energy as well as to replace existing diesel and coal fired power generation..

Tlou listed on the Australian Stock Exchange in 2013 with a large number of UK shareholders and the Company wanted chose to dual list on AIM to take advantage of their UK investor pool.

How we made a differenceGrant Thornton UK were engaged as Nominated Adviser alongside Grant Thornton Australia. The client was sold on our ability to service AIM companies through our teams in the UK and Australia.

Tlou successfully raised £1.2 million (A$2.5 million) through a mixture of existing and new investors from the UK and Australia. The dual listing completed on schedule with only 10 weeks between our appointment and the announcement of the transaction. Tlou was admitted to trading on AIM with a market cap of £12.5 million (A$26.1 million) on 30 November 2015 under the ticker TLOU.

Holly Stiles, Partner - Corporate Finance, who led the deal from Australia, commented: “Tlou has an exciting story and importantly is led by a strong management team with great credentials in the industry. The AIM dual listing allowed us to capitalise on our international network and our experience over 12 years of assisting Australian companies to access the AIM market. Once again, we were able to demonstrate that we can seamlessly service AIM clients across jurisdictions and time zones, resulting in an efficient and high quality level of service which was recognised by our client.”

The deal represents another strong credential for Grant Thornton in the natural resources sector.

“We appointed Grant Thornton because of their AIM experience and because of their coverage both in the UK and Australia. During the admission process, the Grant Thornton team work seamlessly with our other advisers to a tight timetable. The team provided endless support to us and we look forward to working together as we grow as a company.”Colm Cloonan, Executive Director and Chief Financial Officer, Tlou Energy Limited

Case study – Tlou Energy

Our Corporate Finance team acted as Nomad on the AIM dual listing of Tlou Energy Limited in November 2015.

Page 11: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

AIM MARKET | GROWTH FUNDING OPPORTUNITIES FOR AUSTRALIAN COMPANIES | MARCH 2016 11

Could an AIM admission be right for you?

Successful AIM companies come in all shapes and sizes. Could a listing on AIM be the right decision for your organisation? Perhaps some of these questions will resonate with you:

Do you have a funding requirement?Is access to international institutional money an attractive option to management?

Do you have international business operations?Would an increase in profile from an international listing benefit your business operations?

Do you have a strong growth trajectory?Would you benefit from investors who understand and support growth companies?

Do existing shareholders see liquidity?A listing on a stock exchange such as AIM will provide this.

Perhaps you are PE backed and looking for an exit?Now that confidence is returning to the markets, valuations are delivering more attractive exit multiples for PE houses, particularly those only looking for a partial exit.

Do you want to better attract and retain talented employees?Share option schemes in publicly traded companies offer the potential for significant upside and incentivise key staff.

Want to find out more? Grant Thornton is the leading advisor to AIM companies. With over 250 AIM related mandates completed, we have the depth and breadth of experience to help you succeed and achieve your growth aspirations.

We are also the only independent Nominated Advisor to have dedicated specialist staff in both Australia and London, with over 10 years of experience in advising Australian companies on their AIM admissions.

Advisingmorecompaniesthan anyother AIMadvisor

Having executedmore than

250AIM relatedmandates

Acting asauditor to

137AIM companies

Acting asNomad to

companies35

Providingnon-auditservices tomore than

44AIM companies

Page 12: AIM Market - Grant Thornton Australia · MEDITECH China Healthcare 107 1,542 ABCAM UK Healthcare 144 1,324 MARKET TECH HLDG LTD UK Financials 83 991 GW PHARMACEUTICALS USA Healthcare

Key contactHolly StilesPartner, Corporate FinanceT +61 2 8297 [email protected]

Contact Grant Thornton

Grant Thornton is one of the world’s leading organisations of independent assurance, tax and advisory firms. We help dynamic organisations unlock their potential for growth by providing specialist services, business advice and growth solutions.

In Australia, we have more than 1,200 people across six offices in Adelaide, Brisbane, Cairns, Melbourne, Perth and Sydney. We combine service breadth, depth of expertise and industry insight with an approachable ‘client first’ mindset and a broad commercial perspective.

We are a member of Grant Thornton International which comprises firms operating in more than 130 countries worldwide. Through this membership, we access global resources and methodologies that enable us to deliver consistently high quality outcomes for owners and key executives of our clients.

In preparing this publication, we have relied upon the following key sources of information, including: S&P Capital IQ; AIM historical statistics and other publicly available information.

Our analysis is based on the assumption that the information derived from the different sources mentioned above are correct and that no material information is missing. Whilst all reasonable actions have been observed to ensure that the information in this report is not false or misleading, Grant Thornton does not accept any liability for damage incurred as a result of facts or deficiencies in this report. Conclusions and judgements reflect our assessment at the time of the publication's completion.

Grant Thornton Australia Limited ABN 41 127 556 389 ACN 127 556 389

‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to Grant Thornton Australia Limited.

Liability limited by a scheme approved under Professional Standards Legislation. Liability is limited in those States where a current scheme applies.

EPI094

www.grantthornton.com.au